If a patient finds themselves needing it more often than 2 doses per week, a re-evaluation of underlying issues or alternative therapies may be warranted
They may advise maintaining a journal to record symptoms, bowel routines, and alterations in general health status
[DOI] [PMC free article] [PubMed] [Google Scholar] 64.Enooku K., Nakagawa H., Fujiwara N., Kondo M., Minami T., Hoshida Y., Shibahara J., Tateishi R., Koike K
Estimating the remaining G6PD enzyme activity is the most direct, accessible, and reliable assessment of the phenotype and remains the gold standard for the diagnosis of patients who could be harmed by the administration of primaquine
The medication side involves a licensed provider's evaluation and a prescription routed to a retail pharmacy for FDA-approved brand products or to a 503A compounding pharmacy for compounded semaglutide or tirzepatide